ImmuRx Contact Info

Site Map

Home
Company
	Corporate Overview Management Team
		David Delucia, CEO Randolph Noelle, Ph.D, Chief Scientific Officer Hillary White, Ph.D, Vice President of Research and Development Ross Kedl, Ph.D, Director of Research Cory Ahonen, Senior Scientist Robin Teskin, Partner, Hunton & Williams, LLP
Scientific Advisors

Technology
	Science Overview
Recent News
	NIH Awards $537,000 SBIR for Combination Therapies (03/10) ImmuRx Raises $100,000 Seed Funding from Allyon Capital (12/09) Susan Dana Jones, Ph.D., Joins ImmuRx as Vice President of Research & Development (10/09) John G. McHutchison, MD, brings Hep C expertise to Scientific Advisory Board (9/09) NIH Awards $577,000 SBIR for Treatment of Tuberculosis (9/09) ImmuRx Raises Additional Seed Funding from Angeli (6/09) ImmuRx Raises $250,000 Seed Funding from Allyon Capital (6/09) NIH Awards $329,000 SBIR for hCD40 Evaluation (2/09) New Lab Space at Dartmouth Regional Technology Center Key Patent Issued 3M Agreement Antihuman CD40 NHIRC Funding Kedl Lab Award
Publications
Contact
Employment